Nucleosides

<p>2'-Deoxy-N2-DMF-5'-DMT-2'-fluoroguanosine is an anticancer agent that has been modified to contain a 2'-deoxyribonucleoside and a 5'-dimethoxytrityl (DMT) group at the 2' position. The compound inhibits DNA synthesis by binding to the enzyme DNA polymerase, thereby preventing replication. This compound is novel because it contains a deoxyribonucleoside, which is not found in any other anticancer nucleotide analogs. It also has antiviral properties against HIV, herpes simplex virus type 1, and poliovirus.</p>

<p>1,3-Dimethyl-5-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzylidene]-pyrimidine-2,4,6-trione is an activator that is a synthetic analogue of 5-(3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzylidene)-pyrimidine-2. This compound has antiviral and anticancer properties. It is being investigated for its ability to modify DNA in order to inhibit the synthesis of deoxyribonucleosides and ribonucleosides.</p>

<p>5'-O-DMT-N2-Isobutyryl-2'-O-(2-methylacetamido)guanosine 3'-CE phosphoroamidite is a high purity, modified phosphoramidite that is used as an activator for the synthesis of DNA. It is synthesized from 2'-deoxyisobutyrylguanosine and 2-methylacetylamide (N2-iso-butyryl). 5'-O-DMT-N2-Isobutyryl-2'-O-(2-methylacetamido)guanosine 3'-CE phosphoroamidite has a novel structure and is used in anticancer therapy. This compound can be used as a monophosphate or diphosphate nucleotide in DNA synthesis. 5'-O-DMT-N2-Isobutyryl - 2'- O-(2 - methylacetamido)</p>

<p>5'-O-DMT-2'-O-(2-methoxyethyl)-5-methyluridine 3'-CE succinate TEA salt is a novel, modified nucleoside with antiviral activity. It is synthesized from 5'-O-DMT-2'-O-(2-methoxyethyl)-5-methyluridine and the corresponding 2',3',4,4',5,5'-hexachloroacetone adduct. This compound has been shown to be an activator of diphosphate synthesis and ribonucleotide reductase. It is also a potent inhibitor of deoxyribonucleic acid synthesis and tumor cell growth in vitro. The product has been shown to have anticancer properties in vitro and in vivo. The product is not activated by the enzyme phosphodiesterase, which means it does not cause any negative side effects such as hypertension or gastrointestinal disturbance.</p>

<p>2'-Deoxy-5'-O-DMT-guanosine-(DMF)-succinyl-CPG 500 Å is a nucleoside monophosphate that is chemically modified. It is a novel monomer that can be used in the synthesis of phosphoramidites, which are compounds used in the chemical modification of DNA or RNA. It has been shown to inhibit virus replication and activate antiviral responses in cells. 2'-Deoxy-5'-O-DMT-guanosine-(DMF)-succinyl-CPG 500 Å is also a high quality compound with a purity level of 99%.</p>

<p>2'-Deoxyadenosine 5'-monophosphate sodium salt is a hydrated salt that is the sodium salt of 2'-deoxyadenosine 5'-monophosphate. It has been shown to be reactive in particle sequences and to have the ability to cause DNA mutations. Furthermore, this molecule has been found to be an effective inhibitor for cancer cells and also has the potential for use as a therapeutic agent for treating cancers with high levels of mutant p53 tumor suppressor protein.</p>

<p>2,6-Diamino-9-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro-b-D-arabinofuranosyl)purine is a modified nucleoside. It is an antiviral agent that inhibits the replication of DNA by blocking the enzyme DNA polymerase. 2,6-Diamino-9-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro-b-D arabinofuranosyl)purine also has anticancer activity, which may be due to its ability to inhibit the synthesis of RNA and proteins in tumor cells. This compound is not commercially available but can be synthesized on request.</p>

<p>1-(B-D-arabinofuranosyl)cytosine 5'-triphosphate triethylammonium salt is a novel anticancer and antiviral agent that belongs to the group of nucleosides. It has been shown in vitro to inhibit the growth of leukemia and lymphoma cells, as well as to reduce the production of HIV-1 RNA in infected cells. 1-(B-D-arabinofuranosyl)cytosine 5'-triphosphate triethylammonium salt has also been shown to inhibit influenza virus replication at concentrations of 2x10 Molar. This drug is synthesized from deoxyribonucleoside phosphates, with modifications made to the ribonucleotide moiety. The synthesis of this compound requires an activator, which is a metal ion such as copper or zinc.</p>

<p>N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 500 Å is a novel nucleotide analogue that inhibits the growth of cancer cells by inhibiting DNA synthesis. It has been shown to be cytotoxic against leukemia, lymphoma, and breast cancer cells in vitro. N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 500 Å is also an antiviral agent and can inhibit HIV replication. This product is supplied as a white solid powder and is soluble in water.</p>

<p>2'-Deoxy-5-iodo-2-pytimidinone-D-ribose is a nucleoside with antiviral properties. It is synthesized from the nucleotide 2'-deoxy-5-iodo-2-pyrimidinone, which is in turn obtained by substituting the 5' hydroxyl group of pyrimidine with iodine. The compound has been shown to inhibit the synthesis of DNA and RNA in cells infected with viruses. 2'-Deoxy-5-iodo-2-pytimidinone ribose inhibits viral replication by inhibiting the enzyme that catalyzes the conversion of diphosphate to triphosphate. This prevents DNA synthesis, thus preventing viral replication.</p>

<p>5'-Deoxy-5-fluoro-2',3'-O-isopropylidenecytidine is a novel, synthetic nucleoside phosphoramidite. It has been used as an anticancer and antiviral agent. The 5'-deoxy-5-fluoro-2',3'-O-isopropylidenecytidine monophosphate is an activator of DNA and RNA polymerases that are involved in the synthesis of DNA, RNA, and proteins. It has also been shown to inhibit viral replication by interfering with viral DNA synthesis. The chemical name for 5'-deoxy-5-fluoro-2',3'-O-isopropylidenecytidine is 5-(Difluoromethoxy)-N4-[(4S)-4-(dimethylamino)butyl]-2',3'-dideoxycytidine monophosphate.</p>

<p>4-Chloro-5-methyl-7-(2-C-methyl-b-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is a synthetic nucleoside analog that inhibits the viral DNA polymerase and prevents the synthesis of viral DNA. 4CMP 7MRP has antiviral, anticancer, and antiinflammatory activities. This compound is a phosphoramidite nucleoside with a novel scaffold structure that can be used in a variety of applications. It is also highly soluble in water and has high purity.</p>

<p>Ribonucleosides are a group of nucleosides that includes ribose, 2'-deoxyribose, and their derivatives. Ribonucleosides are the building blocks of DNA and RNA. Uridylyl-3'-5'-guanosine ammonium salt is a novel monophosphate nucleotide with antiviral properties. It has been shown to inhibit the synthesis of viral proteins by binding to viral dsDNA and preventing them from being transcribed into mRNA. This drug is also an activator that increases the activity of RNA polymerase II during transcription initiation. The high purity and quality make Uridylyl-3'-5'-guanosine ammonium salt suitable for use in research or as a pharmaceutical ingredient for the manufacture of other drugs.</p>

<p>2'[3']-O-Acetyl-N6-benzoyl-5'-O-DMT-adenosine 3'[2]-O-succinate triethylamine salt is a phosphoramidite that can be used in the synthesis of oligonucleotides. It has antiviral activity and is an activator of ribonucleoside diphosphates. This product is novel and has not been previously described in any literature. The CAS number for this product is 68424-02-4.</p>

<p>Inosine-3',5'-cyclic-monophosphate sodium (cIMP) is a metabolite of inosine and is generated by the enzyme inosine monophosphate cyclohydrolase. cIMP has been shown to be related to colorectal adenocarcinoma, cancer, and body mass index. It has also been implicated in the diagnosis of cancer and infectious diseases. cIMP is involved in energy metabolism and DNA synthesis, which are important for the progression of renal cell cancer. In addition, it has been shown that cIMP can function as a biomarker for prognosis when used with multivariate logistic regression.</p>

<p>5-Iodouridine 5'-triphosphate sodium salt is a novel, synthetic nucleoside. It is used as a starting material for the synthesis of oligoribonucleotides and penta- and hexameric phosphoramidites. The product has antiviral activity in vitro against HIV-1 and influenza A virus.</p>

<p>3',5'-Di-O-acetyl-2-fluoro-2'-O-trifluoromethanesulfonyladenosine is a synthetic antiviral agent that inhibits viral replication via the inhibition of viral DNA polymerase. The drug also has anticancer properties and is active against leukemia, breast cancer, and colon cancer cells. 3',5'-Di-O-acetyl-2-fluoro-2'-O-trifluoromethanesulfonyladenosine has been synthesized in a novel manner by the use of modified nucleosides and phosphoramidites. This compound has high purity and quality.</p>

<p>2',3'-Dideoxyinosine-5'-triphosphate trisodium salt is a modified nucleoside with antiviral activity. It is an analog of deoxyinosine monophosphate that inhibits the growth of cells by inhibiting DNA synthesis. This compound has been shown to be effective against neoplastic cells and has been shown to inhibit the growth of human leukemic cells in vitro. The 2',3'-dideoxyinosine-5'-triphosphate trisodium salt is synthesized, purified, and characterized by high performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR). 2',3'-Dideoxyinosine-5'-triphosphate trisodium salt is chemically synthesized from 2',3'-dideoxyinosine monophosphate, which is reacted with sodium triphosphate in water to produce 2',3'-dideoxyinosine-5'-triph</p>

<p>N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 1400 Å is a novel synthetic nucleoside with antiviral activity. It is phosphorylated to the corresponding monophosphate and diphosphate, which are then incorporated into DNA as deoxyribonucleosides. N4-Benzoyl-2'-deoxy-5'-O-DMT-cytidine 3'-succinyl CPG 1400 Å is an activator of DNA polymerase η and κ.</p>

<p>gamma-(BBT)-GTP is a synthetic nucleoside phosphoramidite that is used in the synthesis of DNA and RNA. It has antiviral properties and can be used as an activator of DNA polymerase in the deoxyribonucleotide synthesis. This chemical is novel because it can be modified to contain a phosphate group at the 2'-position, which is not found in natural nucleosides or nucleotides. gamma-(BBT)-GTP is a high-purity chemical that can be synthesized using CAS No. 72335-45-2.</p>